This investigation, conducted on a Turkish cohort of 150 patients with clinicopathological data, revealed moderate to strong SOX9 intensity in 85.3% of cases, with high SOX9 expression observed in 40% of gastric carcinoma cases. This evidence concerns the gene SOX9 and gastric carcinoma.